Spots Global Cancer Trial Database for imprime pgg + cetuximab
Every month we try and update this database with for imprime pgg + cetuximab cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
---|---|---|---|---|---|---|
Study of Imprime PGG® in Combination With Cetuximab in Subjects With Recurrent or Progressive KRAS Wild Type Colorectal Cancer | NCT01309126 | Colorectal Canc... | Imprime PGG + c... Cetuximab | 18 Years - | HiberCell, Inc. | |
Study of Imprime PGG® in Combination With Cetuximab in Subjects With Recurrent or Progressive KRAS Wild Type Colorectal Cancer | NCT01309126 | Colorectal Canc... | Imprime PGG + c... Cetuximab | 18 Years - | HiberCell, Inc. |